Congenital heart disease and pregnancy
https://doi.org/10.23946/2500-0764-2019-4-3-102-112
Abstract
Annually, there > 30,000 infants are born with congenital heart defects; in different populations, the prevalence of congenital heart disease (CHD) varies from 2.4 to 14.15%. Women with CHD planning pregnancy are at increased risk of heart failure, arrhythmias, cerebrovascular disease, and embolism. In such patients, pregnancy course is complicated by intrauterine growth restriction, pre-eclampsia, and preterm birth. Their newborns generally have a low birth weight and high risk of congenital malformations including heart defects. European Society of Cardiology (ESC) developed risk assessment-based guidelines to optimise the management of pregnant women with CHD. This approach requires a cooperation of obstetrician-gynecologists, general practitioners, and cardiologists.
About the Authors
E. V. Rudaeva
Kemerovo State Medical University
Russian Federation
Russian Federation
MD, PhD, Associate Professor, Department of Obstetrics and Gynecology,
22a, Voroshilova Street, Kemerovo, 650056
V. G. Mozes
Kemerovo State Medical University
Russian Federation
Russian Federation
MD, DSc, Professor, Department of Obstetrics and Gynecology,
22a, Voroshilova Street, Kemerovo, 650056
V. V. Kashtalap
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Russian Federation
MD, DSc, Head of the Laboratory for Pathophysiology of Atherosclerosis, Division of Atherosclerosis Research,
6, Sosnovy Boulevard, Kemerovo, 650002
I. S. Zakharov
Kemerovo State Medical University
Russian Federation
Russian Federation
MD, DSc, Professor, Department of Obstetrics and Gynecology,
22a, Voroshilova Street, Kemerovo, 650056
S. I. Yelgina
Kemerovo State Medical University
Russian Federation
Russian Federation
MD, DSc, Professor, Department of Obstetrics and Gynecology,
22a, Voroshilova Street, Kemerovo, 650056
E. G. Rudaeva
Kemerovo State Medical University
Russian Federation
Russian Federation
MD, PhD, Associate Professor, Department of Pediatric Diseases,
22a, Voroshilova Street, Kemerovo, 650056
References
1. Aylamazyan EK, Kulakov VI, Radzinsky VE, Saveliev GM, eds. Obstetrics. National guidelines. M.: GEOTAR-MediaPubl; 2014:668-674. (In Russ.).
2. Apresyan SV, Radzinsky VE. Pregnancy and childbirth in extragenital pathology. M.: GEOTAR-MediaPubl; 2009:75-169. (In Russ.).
3. Roos-Hesselink JW, Ruys TP, Stein J, Thilen U, Webb GD, Niwa K, Kaemmerer H, Baumgartner H, Budts W, Maggioni AP, Tavazzi L, Taha N, Johnson MR, Hall R; ROPAC Investigators. Outcome of pregnancy in patients with structural or ischaemicheart disease: results of a registry of the European Society of Cardiology. Eur Heart J. 2013;34(9):657-665. DOI: 10.1093/eurheartj/ehs270
4. Drenthen W, Boersma E, Balci A, Moons P, Roos-Hesselink JW, Mulder BJ, Vliegen HW, van Dijk AP, Voors AA, Yap SC, van Veldhuisen DJ, Pieper PG; ZAHARA Investigators. Predictors of pregnancy complications in women with congenital disease. Eur Heart J. 2010;31(17): 2124-2132.
5. Mravyan SR, Petrukhin VA, Pronin VP. Heart defects in pregnant women. SPb: GEOTARMmedia; 2010. (In Russ.).
6. Stryuk RI. Diseases of the cardiovascular system and pregnancy. M.: GEOTAR-MediaPubl; 2010. (In Russ.).
7. European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM), Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Gorenek B, Iung B, Kirby M, Maas AH, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L; ESC Committee for Practice Guidelines.Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the management of Cardiovascular Diseases during Pregnancy. Eur Heart J. 2011;32(24):3147-3197. DOI: 10.1093/eurheartj/ehr218
8. Oakley S, Warren S. Heart diseases in pregnant women. SPb: Binom; 2010. (In Russ.).
9. Fernandes SM, Arendt KW, Landzberg MJ, Economy KE, Khairy P. Pregnant women with congenital heart disease: cardiac, an anaesthetic and obstetrical implications. Expert Rev Cardiovasc Ther. 2010;8(3):439-448. DOI: 10.1586/erc.09.179
10. Shechtman MM. Manual of extragenital pathology in pregnant women. M.: Triad-X; 2008. (In Russ.).
11. Sokolova MYu. Extragenital pathology in pregnant women: a guide for doctors. M.: MIA, 2011. (In Russ.).
12. Martsevich SY, eds. Diagnosis and treatment of cardiovascular diseases during pregnancy. Recommendations RCO. Rossiiskiy kardiologicheskiy zhurnal. 2013;18(4S1):1-40.
13. Arutyunov GP. Diagnosis and treatment of diseases of the heart and blood vessels. M: GEOTAR-MediaPubl; 2013: 275-300. (In Russ.).
14. Order of the Ministry of Health of the Russian Federation of 01.11.2012. No. 572n “On approval of the procedure for providing medical care in the profile of obstetrics and gynecology (with the exception of the use of assisted reproductive technologies) with changes as of 06.11.2015. Accessed August 2019(In Russ.). https://base.garant.ru/70352632/
15. Martsevich SY, eds. Rational pharmacotherapy of patients with cardiovascular diseases. Kardiovaskulyarnaya terapiya i profilaktika. 2009;8(6)(suppl 4):1-51. (In Russ.).
Review
For citations:
Rudaeva E.V., Mozes V.G., Kashtalap V.V., Zakharov I.S., Yelgina S.I., Rudaeva E.G. Congenital heart disease and pregnancy. Fundamental and Clinical Medicine. 2019;4(3):102-112. (In Russ.) https://doi.org/10.23946/2500-0764-2019-4-3-102-112
Views:
8106
Email this article 